Model DetailsUterus adenocarcinoma
Model Name |
Uterus adenocarcinoma | Strain |
CD-1 |
Tumor Inducing Agent(s) |
Hormone : diethylstilbestrol (DES) |
Tumor Synonym |
uterine adenocarcinoma |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Uterus | Female |
6.9% (2 of 29 mice) |
17-19 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Uterus | Female |
8.6% (3 of 35 mice) |
22-24 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Uterus | Female |
5.7% (2 of 35 mice) |
17-19 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Uterus | Female |
16% (6 of 37 mice) |
22-24 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Uterus | Female |
0% (0 of 16 mice) |
17-19 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Uterus | Female |
0% (0 of 24 mice) |
22-24 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Uterus | Female |
0% (0 of 33 mice) |
17-19 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Uterus | Female |
6.7% (1 of 15 mice) |
22-24 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Uterus | Female |
3.4% (1 of 29 mice) |
17-19 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Uterus | Female |
11% (4 of 36 mice) |
22-24 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Uterus | Female |
7.8% (5 of 64 mice) |
17-24 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Lymph node | Female |
observed |
17-24 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Uterus | Female |
10% (1 of 10 mice) |
13 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |
| Uterus | Female |
5.0% (1 of 20 mice) |
12-17 months |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 |